Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results Hims & Hers Health delivered a mixed earnings report and announced a potential Wegovy partnership with Novo Nordisk; the downside…
Hims & Hers in talks with Novo Nordisk over Wegovy return Less than six months after ending a short-lived partnership, US telehealth firm Hims & Hers (Nasdaq: HIMS) and Danish drugmaker…
Analysts Issue Forecasts for HIMS Q3 Earnings Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn issued their Q3 2026…
Mission Wealth Management LP Acquires Shares of 10,300 Hims & Hers Health, Inc. $HIMS Mission Wealth Management LP acquired a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during…
Arkadios Wealth Advisors Acquires New Shares in Hims & Hers Health, Inc. $HIMS Arkadios Wealth Advisors purchased a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…
Teacher Retirement System of Texas Purchases 6,925 Shares of Hims & Hers Health, Inc. $HIMS Teacher Retirement System of Texas boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free…
Hims & Hers Health (HIMS) Revenue Growth Forecast Tops Market, Elevating Debate on Valuation Premium Hims & Hers Health (HIMS) posted strong revenue and earnings growth forecasts, with revenue expected to rise 14.7% per year…
Hims & Hers Health (HIMS) Margin Compression Challenges Bullish Narratives Despite Sustained Profit Growth Hims & Hers Health (HIMS) has posted average annual earnings growth of 62.2% over the past five years and current…